以表阿霉素为基础的化疗对女性乳腺癌合并糖尿病患者心脏毒性的影响被引量：2

下载PDF

导出

摘要术后病理检查确诊的乳腺癌患者60例,均实施以表阿霉素为基础对化疗治疗,合并2型糖尿病患者者30例为糖尿病化疗组,不合并糖尿病30例为非糖尿病化疗组,无癌女性2型糖尿病患者30例为糖尿病对照组。结果:化疗结束后,糖尿病化疗组的#Ea、#E/Ea与糖尿病对照组、非糖尿病化疗组相比差异显著(P <0.05),但三组的#Sa对比无差异(P>0.05);三组化疗后两两组间对比#SOD、#MDA水平差异显著(P <0.05)。结论:以表阿霉素为基础化疗可能会导致乳腺癌合并糖尿病患者的心脏功能受损加重。

作者张云飞

机构地区周口永善医院

出处《实用糖尿病杂志》 2020年第3期74-75,共2页 Journal of Practical Diabetology

关键词表阿霉素女性乳腺癌糖尿病心脏毒性

分类号 R737.9 [医药卫生—肿瘤] R587.2 [医药卫生—内分泌]

引文网络
相关文献

参考文献3

1刘红梅,刘世专,黄卫俊,孙成晖,严伟红.稳心颗粒在乳腺癌蒽环类化疗引起心脏毒性患者中的应用及预后[J].中国现代药物应用,2017,11(8):123-124. 被引量：5
2刘桂红,周卫华,张玉娜,刘月芹,朱铁年.乳腺癌合并2型糖尿病患者的临床病理特征及预后分析[J].河北医科大学学报,2016,37(3):249-251. 被引量：18
3王媛,周浩行.表阿霉素化疗对乳腺癌合并糖尿病患者的心电损伤[J].糖尿病新世界,2016,19(22):62-63. 被引量：1

二级参考文献35

1陈灏珠,钟南山,陆再英.内科学[M].8版.北京:人民卫生出版社,2013:624-626.
2Gouveri E, Papanas N, Maltezos E. The female breast and diabetes[J]. Breast,2011,20(3) :205--211.
3Khachatryan L, Seharpf R, Kagan S. Influence of diabetes mellitus ~ype 2 and prolonged estrogen exposure on risk of breast cancer among women in Armenia[J]. Health Care Women Int,2011,32(11) :953--971.
4Zhang PH,Chen ZW, Lv D, et al. Increased risk of cancer in patients with type 2 diabetes meilitus., a retrospective cohort study in China[J]. BMC Public Health,2012,12:567.
5Sehraude~ MG, Fasching PA, Haberle L, et al. Diabetes and prognosis in a breast cancer Cohort[J]. J Cancer Res Clin Oncol,2011,137(6) :975--983.
6de Bruijn KM, Arends LR, Hansen BE, et al. Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast a~nd colorectal cancer[J]. Br J Surg,2013,100(11) :1421-1429.
7Liu X,Ji J,Sundquist K, et al. The impact of type 2 diabetes mellitus on cancer-specific survival[J].Cancer, 2012,118 ( 5 ): 1353--1361.
8Jemal A, Bray F, Center MM, et al. Global cancer statistics [J]. CA Cancer J Clin,2011,61(2) :69--90.
9Yang SH, Dou KF, Song WJ. Prevalence of diabetes among men and women in China[J].N Engl J Med,2010,362(25) : 2425--2426.
10Kaplan MA,Pekkolay Z,Kucukoner M,et al. Type 2 diabetes mellitus and prognosis in early stage breast cancer women[J]. Med Oncol,2012,29(3) :1576--1580.